The growth of the psychedelic industry is usually compared to how medical cannabis burst onto the scene, but things appear to be moving with even more urgency for psychedelics. The FDA recently labeled Psilocybin therapy as a “breakthrough therapy,” and the Veteran’s Administration has approved the use of psychedelic medicine for soldiers to treat their PTSD.
The “Coming Golden Age of Psychedelic Medicine” is upon us. Join us to learn how you can become a conscious investor of the psychedelic industry!
During our next webinar, Arcview Capital, DealMaker, and Ei.Ventures will share:
Head of Intermediary Sales & Fund Distribution, Arcview Capital
Chief Executive Officer & Co-Founder of DealMaker
Co-Founder and Chief Strategy Officer of Ei. Ventures
Dr. Linda Strause Ph.D,
Director of Clinical Development of Ei. Ventures
Product Development of Ei. Ventures